Oracle's Sales Are Soaring, But Its Stock Is Falling. Time to Buy?

Oracle reported fiscal Q3 revenue up 22% y/y to $17.2B, cloud revenue +44% to $8.9B and cloud infrastructure revenue +84% y/y to $4.9B; non‑GAAP EPS rose 21% to $1.79. Remaining performance obligations (RPO) jumped 325% y/y to $553B, driven by large AI contracts, while management plans to raise $45–50B of debt and equity in 2026 and has initiated large layoffs to fund aggressive data‑center buildout. The capital‑intensive strategy pressures free cash flow and elevates leverage risk even as sales and backlog are strong; shares are down ~26% YTD and over 50% from the September peak, creating a high‑risk, high‑reward investment case.

Analysis

Oracle’s spending pivot creates a bifurcated ecosystem: GPU/accelerator suppliers and data‑center infrastructure vendors stand to capture outsized incremental margin, while incumbents that rely on low‑growth software maintenance revenues will see a longer, costlier transition to an AI‑first revenue base. Expect inventory and lead‑time dynamics to shift away from traditional enterprise channels toward direct OEM relationships and equipment‑finance models; that amplifies upside for suppliers who can sell turnkey racks or financing rather than just chips.

Key risks live on two distinct timelines. In the near term (days–months) the primary driver is sentiment around financing cadence and covenant language — any sign of market refusal to underwrite new issuance will blow out spreads and force dilution or asset sales. Over the medium term (6–24 months) the main execution risks are underutilized new capacity and accelerating tech obsolescence (next‑gen accelerators that make recent installs suboptimal), both of which would compress free cash flow conversion and raise restructuring probability.

Second‑order financing and structuring options materially change outcomes: contracted AI deployments are often paired with take‑or‑pay minimums, monthly usage cliffs, or customer‑backed equipment financing — mechanisms that can be monetized (securitization, sale‑leaseback, vendor finance JV) to de‑risk the balance sheet before cash flow fully accrues. That suggests the market may be overpricing a binary default outcome when more realistic scenarios include staged monetization and non‑dilutive financing that preserve optionality.

Actionable monitorables that will resolve this debate in the next 4 quarters are: cadence and structure of external financing, percentage of new capacity pre‑funded by customers or third‑party financiers, incremental gross margins on AI workloads, and any negative change in bank or rating‑agency covenant metrics. Those four items will move valuation from “speculative” to either “scaled opportunity” or “overlevered risk.”

Key Decisions for Investors

• Long ORCL equity (size 2–3% NAV), horizon 12–18 months, hedge with a 9‑month put ~10% OTM sized 50% of the equity notional to cap downside; R/R: asymmetric upside if FCF conversion begins (target +30%–40%), defined downside to the hedge cost plus strike gap.
• Volatility play: buy a 3–6 month ORCL straddle or a long strangle around the next large financing or earnings date (expected vol > realized vol); take profits on a >25% share move or when realized vol exceeds implied, cut if premium decays >50% within half the term.
• Pair/options trade (structural demand): buy 9–12 month NVDA call spread (bullish on accelerator demand) funded by selling 6–9 month ORCL cash‑secured puts at a strike you’re comfortable owning; directional long GPU exposure with limited financing risk — target 2:1 reward/risk.
• Credit hedge: establish a small CDS protection position or short newly issued ORCL paper in the 5–7 year part of the curve if the company formally announces large gross issuance with weak covenant terms; aim for >100bp spread widening breakeven, stop if issuance priced with strong bank support.
• Event trigger rules: reduce ORCL equity exposure by 50% if (a) financing package lacks non‑dilutive structures, (b) >1 major customer delays payments/shipments, or (c) rating agency issues a negative outlook; conversely add if quarterly reported contracted cash receipts and incremental gross margins accelerate versus guidance.